Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

ReSound® Returns to the World’s Largest Consumer Electronics Show in Berlin to Showcase the Most Advanced Hearing Solutions

Posted on: 01 Sep 16

ReSound returns this week to IFA, the world’s largest international consumer electronics show, to feature its award winning Smart Hearing aids and to help lead the current discussion on how to support hearing health care professionals in their task of creating highest satisfaction for people with hearing loss, during fitting process and day-to-day life. More than 500 million people worldwide suffer from hearing loss, including 13 to 15 million Germans.

Consumers and members of the news media are invited to experience ReSound Smart Hearing at the ReSound booth, found in Hall 7.2b 201.

ReSound LiNX2™ and ReSound ENZO2™ are the world’s first and only full family of advanced hearing aids with Made for iPhone capabilities and comes with the awarded ReSound Smart app free of charge in the Apple App Store, and for several Android devices in the Google Play Store. ReSound representatives will provide visitors with interactive demonstrations of the full ecosystem of ReSound Smart Hearing solutions, which allow wearers to stream sounds directly from their iPhone®, iPad®, or iPod touch® to their hearing aids.

ReSound Smart Hearing leverages ReSound’s proprietary 2.4 GHz wireless platform, allowing wearers to personalize their hearing like never before by delivering the power of direct control over hearing aid settings through the ReSound Smart app. ReSound’s industry-leading technologies put customization at the users’ fingertips, allowing wearers to make adjustments in real-time based on personal preference and listening environment.

ReSound’s full family of Smart Hearing aids improve hearing outcomes for people of all ages and for all types of hearing loss. The ReSound Smart Hearing portfolio provides solutions for children, teenagers and adults, including those with mild-to-moderate or severe-to-profound hearing loss.

“IFA is one of the most important places to feature the latest in health care innovation,” said GN Hearing CEO Anders Hedegaard. “In addition to featuring ReSound’s portfolio of Smart Hearing solutions, we will be driving the discussion on innovations in audiology and hearing care that tackle important obstacles to achieving even higher user satisfaction and more effortless, natural hearing for users of ReSound products worldwide.”

Members of the news media are encouraged to schedule an interview with company representatives.
For English speaking media: Please contact John Procter at
For German speaking media: Please contact Martin Schaarschmidt at

ReSound’s revolutionary portfolio of Smart Hearing aid technology is available through a global network of hearing care professionals. Consumers can find more information by visiting

About GN Hearing

GN Hearing is a leading international developer and manufacturer of innovative hearing healthcare solutions committed to let people hear more, do more and be more than they ever thought possible. The company has reinvented the hearing system with its revolutionary ReSound Smart Hearing aids that give impressive sound and personal freedom to hearing aid users through wireless smartphone and tablet connectivity. ReSound is part of GN Group comprising a unique portfolio of medical, professional and consumer sound solutions that make life sound better through its research, insights, and expertise in sound.

View source version on

Business Wire

Last updated on: 01/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.